Skip to main content
Equibles

US BANCORP \DE\

Bank

Position in ANIX — Anixa Biosciences Inc

CIK 36104 MINNEAPOLIS, MN
Back to ANIX Full portfolio

Position in ANIX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,120
+$88 QoQ
Shares Held
400
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 62 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

US BANCORP \DE\ holds $83,094,208 across 214 Biotechnology names. ANIX ranks #187 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AXSM
Axsome Therapeutics, Inc.
 66,580 $16,296,786
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 32,020 $15,905,293
3 TECH
BIO-TECHNE Corp
 137,966 $9,747,297
4 REGN
Regeneron Pharmaceuticals, Inc.
 5,330 $3,323,466
5 ARGX
Argenx SE
 3,495 $3,242,555
6 ARWR
Arrowhead Pharmaceuticals, Inc.
 38,226 $3,115,799
7 JAZZ
Jazz Pharmaceuticals plc
 10,103 $2,434,518
8 GMAB
Genmab A/S
 88,420 $2,428,896

All Filings in ANIX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,120 400
2026-03-31 $1,032 400
2025-12-31 $1,248 400
2025-09-30 $1,320 400
2025-06-30 $1,320 400
2025-03-31 $1,144 400
2024-12-31 $928 400
2024-09-30 $1,260 400
2024-06-30 $884 400
2024-03-31 $1,248 400
2023-12-31 $1,552 400
2023-09-30 $1,308 400
2023-06-30 $1,280 400
2023-03-31 $1,720 400
2022-12-31 $1,700 400
2022-09-30 $1,968 400
2022-06-30 $1,224 400
2022-03-31 $37,398 13,649
2021-12-31 $1,188 400